These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 28045459)

  • 1. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
    Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Abundance and Co-occurrence of
    Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa.
    Fitzgerald CB; Shkoporov AN; Sutton TDS; Chaplin AV; Velayudhan V; Ross RP; Hill C
    BMC Genomics; 2018 Dec; 19(1):931. PubMed ID: 30547746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the relative abundance of
    Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
    Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
    Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
    J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of Faecalibacterium prausnitzii in human health: An overview.
    Leylabadlo HE; Ghotaslou R; Feizabadi MM; Farajnia S; Moaddab SY; Ganbarov K; Khodadadi E; Tanomand A; Sheykhsaran E; Yousefi B; Kafil HS
    Microb Pathog; 2020 Dec; 149():104344. PubMed ID: 32534182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
    Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
    Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile.
    Marcos-Fernández R; Riestra S; Alonso-Arias R; Ruiz L; Sánchez B; Margolles A
    Microbiol Spectr; 2023 Feb; 11(1):e0181722. PubMed ID: 36598219
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of
    Ueda A; Shinkai S; Shiroma H; Taniguchi Y; Tsuchida S; Kariya T; Kawahara T; Kobayashi Y; Kohda N; Ushida K; Kitamura A; Yamada T
    Cell Rep Med; 2021 Sep; 2(9):100398. PubMed ID: 34622235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes.
    Cornuault JK; Petit MA; Mariadassou M; Benevides L; Moncaut E; Langella P; Sokol H; De Paepe M
    Microbiome; 2018 Apr; 6(1):65. PubMed ID: 29615108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from
    Auger S; Kropp C; Borras-Nogues E; Chanput W; Andre-Leroux G; Gitton-Quent O; Benevides L; Breyner N; Azevedo V; Langella P; Chatel JM
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.
    Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W
    Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851
    [No Abstract]   [Full Text] [Related]  

  • 17. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.
    Lindstad LJ; Lo G; Leivers S; Lu Z; Michalak L; Pereira GV; Røhr ÅK; Martens EC; McKee LS; Louis P; Duncan SH; Westereng B; Pope PB; La Rosa SL
    mBio; 2021 Jun; 12(3):e0362820. PubMed ID: 34061597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of 84
    Bai Z; Zhang N; Jin Y; Chen L; Mao Y; Sun L; Fang F; Liu Y; Han M; Li G
    Front Cell Infect Microbiol; 2022; 12():919701. PubMed ID: 36683686
    [No Abstract]   [Full Text] [Related]  

  • 19. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth.
    Lopez-Siles M; Khan TM; Duncan SH; Harmsen HJ; Garcia-Gil LJ; Flint HJ
    Appl Environ Microbiol; 2012 Jan; 78(2):420-8. PubMed ID: 22101049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.